Beta Drugs Limited (NSEI: BETA)
Health Care · Pharmaceuticals · IN
Rs2,073.30
-1.21% today · +16.2% 1Y
Beta Drugs Limited (NSEI: BETA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $218.29M.
Over the last twelve months the share price has gained 16.2%, trading between 990.10 and 2.81K.
Tweenvest scores Beta Drugs Limited across four factors: quality 81/100, value 37/100, growth 79/100. Its strongest factor is quality.
BETA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $218.29M
- Revenue (TTM)
- $43.38M
- P/E
- 46.79
- EPS
- 44.31
- Dividend yield
- —
- Beta (5Y)
- -0.37
- 52-week high
- Rs2,807.90
- 52-week low
- Rs990.10
- Avg volume (3M)
- —
- Shares outstanding
- 10.14M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SIGA Technologies, Inc.NasdaqGM: SIGA | $234.23M | $3.28 | +0.61% |
| Syncom Formulations (India) LimitedBSE: 524470 | $234.02M | Rs23.97 | +19.49% |
| Fredun Pharmaceuticals LimitedBSE: 539730 | $232.40M | Rs1,353.00 | -0.58% |
| JW Holdings CorporationKOSE: A096760 | $220.15M | ₩4,285.00 | -0.92% |
| Imexpharm CorporationHOSE: IMP | $216.92M | ₫36,600.00 | -0.81% |
| Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)CASE: RMDA | $211.63M | EGP5.45 | -5.55% |
| SCI Pharmtech, Inc.TWSE: 4119 | $208.59M | NT$55.60 | -1.94% |
| Newron Pharmaceuticals S.p.A.SWX: NWRN | $207.97M | CHF8.12 | -22.37% |
Figures last refreshed Oct 4, 2026.